Portal:AOP/FeaturedPathways
From WikiPathways
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | *[[Pathway:WP3997]] Epilepsy Adverse Outcome Pathway (Homo sapiens) | + | *[[Pathway:WP3997]] : Epilepsy Adverse Outcome Pathway (Homo sapiens) |
| - | *[[Pathway:WP3980]] Protein alkylation leading to liver fibrosis (Homo sapiens) | + | *[[Pathway:WP3980]] : Protein alkylation leading to liver fibrosis (Homo sapiens) |
| - | *[[Pathway:WP3624]] Lung fibrosis (Homo sapiens) | + | *[[Pathway:WP3624]] : Lung fibrosis (Homo sapiens) |
| - | *[[Pathway:WP3632]] Lung fibrosis (Mus musculus) | + | *[[Pathway:WP3632]] : Lung fibrosis (Mus musculus) |
| - | *[[Pathway:WP4010]] Liver steatosis AOP (Homo sapiens) | + | *[[Pathway:WP4010]] : Liver steatosis AOP (Homo sapiens) |
| - | *[[Pathway:WP4011]] Steatosis AOP (Homo sapiens) | + | *[[Pathway:WP4011]] : Steatosis AOP (Homo sapiens) |
| - | *[[Pathway:WP4017]] Selective serotonin reuptake inhibitors lead to several adverse outcomes (Homo sapiens) | + | *[[Pathway:WP4017]] : Selective serotonin reuptake inhibitors lead to several adverse outcomes (Homo sapiens) |
| - | *[[Pathway:WP4026]] Gastric ulcer formation (Homo sapiens) | + | *[[Pathway:WP4026]] : Gastric ulcer formation (Homo sapiens) |
Revision as of 10:36, 23 March 2018
- Pathway:WP3997 : Epilepsy Adverse Outcome Pathway (Homo sapiens)
- Pathway:WP3980 : Protein alkylation leading to liver fibrosis (Homo sapiens)
- Pathway:WP3624 : Lung fibrosis (Homo sapiens)
- Pathway:WP3632 : Lung fibrosis (Mus musculus)
- Pathway:WP4010 : Liver steatosis AOP (Homo sapiens)
- Pathway:WP4011 : Steatosis AOP (Homo sapiens)
- Pathway:WP4017 : Selective serotonin reuptake inhibitors lead to several adverse outcomes (Homo sapiens)
- Pathway:WP4026 : Gastric ulcer formation (Homo sapiens)
